51 related articles for article (PubMed ID: 34372567)
21. Insights into molecular therapy of glioma: current challenges and next generation blueprint.
Rajesh Y; Pal I; Banik P; Chakraborty S; Borkar SA; Dey G; Mukherjee A; Mandal M
Acta Pharmacol Sin; 2017 May; 38(5):591-613. PubMed ID: 28317871
[TBL] [Abstract][Full Text] [Related]
22. Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells.
Balvers RK; Dirven CM; Leenstra S; Lamfers ML
Curr Cancer Drug Targets; 2017; 17(3):255-266. PubMed ID: 27528360
[TBL] [Abstract][Full Text] [Related]
23. Large-scale assessment of the gliomasphere model system.
Laks DR; Crisman TJ; Shih MY; Mottahedeh J; Gao F; Sperry J; Garrett MC; Yong WH; Cloughesy TF; Liau LM; Lai A; Coppola G; Kornblum HI
Neuro Oncol; 2016 Oct; 18(10):1367-78. PubMed ID: 27116978
[TBL] [Abstract][Full Text] [Related]
24. Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach.
Spanevello F; Calistri A; Del Vecchio C; Mantelli B; Frasson C; Basso G; Palù G; Cavazzana M; Parolin C
Mol Ther Nucleic Acids; 2016 Apr; 5(4):e312. PubMed ID: 27093170
[TBL] [Abstract][Full Text] [Related]
25. Survival in glioblastoma: a review on the impact of treatment modalities.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2016 Nov; 18(11):1062-1071. PubMed ID: 26960561
[TBL] [Abstract][Full Text] [Related]
26. Targeting protein kinase A in cancer therapy: an update.
Sapio L; Di Maiolo F; Illiano M; Esposito A; Chiosi E; Spina A; Naviglio S
EXCLI J; 2014; 13():843-55. PubMed ID: 26417307
[TBL] [Abstract][Full Text] [Related]
27. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
[TBL] [Abstract][Full Text] [Related]
28. Molecular targets in glioblastoma.
Zorzan M; Giordan E; Redaelli M; Caretta A; Mucignat-Caretta C
Future Oncol; 2015; 11(9):1407-20. PubMed ID: 25952786
[TBL] [Abstract][Full Text] [Related]
29. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.
Dahan P; Martinez Gala J; Delmas C; Monferran S; Malric L; Zentkowski D; Lubrano V; Toulas C; Cohen-Jonathan Moyal E; Lemarie A
Cell Death Dis; 2014 Nov; 5(11):e1543. PubMed ID: 25429620
[TBL] [Abstract][Full Text] [Related]
30. Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule.
Kang TW; Choi SW; Yang SR; Shin TH; Kim HS; Yu KR; Hong IS; Ro S; Cho JM; Kang KS
Sci Rep; 2014 Jul; 4():5546. PubMed ID: 24989033
[TBL] [Abstract][Full Text] [Related]
31. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.
Auffinger B; Tobias AL; Han Y; Lee G; Guo D; Dey M; Lesniak MS; Ahmed AU
Cell Death Differ; 2014 Jul; 21(7):1119-31. PubMed ID: 24608791
[TBL] [Abstract][Full Text] [Related]
32. An optimized microRNA backbone for effective single-copy RNAi.
Fellmann C; Hoffmann T; Sridhar V; Hopfgartner B; Muhar M; Roth M; Lai DY; Barbosa IA; Kwon JS; Guan Y; Sinha N; Zuber J
Cell Rep; 2013 Dec; 5(6):1704-13. PubMed ID: 24332856
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase a in cancer.
Caretta A; Mucignat-Caretta C
Cancers (Basel); 2011 Feb; 3(1):913-26. PubMed ID: 24212646
[TBL] [Abstract][Full Text] [Related]
34. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.
Gilbert MR; Wang M; Aldape KD; Stupp R; Hegi ME; Jaeckle KA; Armstrong TS; Wefel JS; Won M; Blumenthal DT; Mahajan A; Schultz CJ; Erridge S; Baumert B; Hopkins KI; Tzuk-Shina T; Brown PD; Chakravarti A; Curran WJ; Mehta MP
J Clin Oncol; 2013 Nov; 31(32):4085-91. PubMed ID: 24101040
[TBL] [Abstract][Full Text] [Related]
35. Improving prognosis of glioblastoma in the 21st century: who has benefited most?
Lawrence YR; Mishra MV; Werner-Wasik M; Andrews DW; Showalter TN; Glass J; Shen X; Symon Z; Dicker AP
Cancer; 2012 Sep; 118(17):4228-34. PubMed ID: 22180310
[TBL] [Abstract][Full Text] [Related]
36. Acidic stress promotes a glioma stem cell phenotype.
Hjelmeland AB; Wu Q; Heddleston JM; Choudhary GS; MacSwords J; Lathia JD; McLendon R; Lindner D; Sloan A; Rich JN
Cell Death Differ; 2011 May; 18(5):829-40. PubMed ID: 21127501
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
[TBL] [Abstract][Full Text] [Related]
38. Differentiation therapy exerts antitumor effects on stem-like glioma cells.
Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C
Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299
[TBL] [Abstract][Full Text] [Related]
39. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
[TBL] [Abstract][Full Text] [Related]
40. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.
Seidel S; Garvalov BK; Wirta V; von Stechow L; Schänzer A; Meletis K; Wolter M; Sommerlad D; Henze AT; Nistér M; Reifenberger G; Lundeberg J; Frisén J; Acker T
Brain; 2010 Apr; 133(Pt 4):983-95. PubMed ID: 20375133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
